Research and development - Press Releases

Date	Title	Company
27-Apr-2021	Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.	Moderna
26-Apr-2021	Microbix & SpeeDx Form Exclusive Collaboration	Microbix
26-Apr-2021	Selumetinib recommended for approval in the EU by CHMP as the first medicine for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas	AstraZeneca
26-Apr-2021	Tagrisso recommended for approval in the EU by CHMP for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer	AstraZeneca
23-Apr-2021	Registration Opens for SMi's Aseptic Processing Conference 2021	SMi Group
23-Apr-2021	Bristol Myers Squibb Invests in Europe with New Cell Therapy Manufacturing Site Planned in the Netherlands	Bristol Myers Squibb
23-Apr-2021	DFE Pharma Launches Ultimate Excipient Solution for Biopharma	DFE Pharma
23-Apr-2021	GutFlora Omics Platform Releases Total RNA Sequencing Service	Creative Proteomics
22-Apr-2021	Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine	Johnson & Johnson
21-Apr-2021	Evotec invests into Oxford Cell Therapy Company "OxVax"	Evotec
21-Apr-2021	Alfa Chemistry Released Four Types of Featured Products for the Research Community	Alfa Chemistry
21-Apr-2021	Amerigo Scientific Introduces SARS-CoV-2 IgM/IgG Antibody Test Kit to Researchers	Amerigo Scientific
21-Apr-2021	CD Bioparticles Introduces Lipid Nanoparticle Formulation and Development for mRNA Vaccine Delivery	CD Bioparticles
20-Apr-2021	Amgen's Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy Designation	Amgen
16-Apr-2021	Clinerion adds Patient Network Explorer coverage to four new hospitals in Brazil, bringing the total to 17 hospitals and over 7 million patients.	Clinerion Ltd.
16-Apr-2021	GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19	GSK
16-Apr-2021	Merck to Discontinue Development of MK-7110 for COVID-19	Merck
15-Apr-2021	Top 10 Reasons to join SMi's 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference	SMi Group
15-Apr-2021	Oxitec Receives Landmark Biosafety Approval for New Fall Armyworm Control Solution	Oxitec
15-Apr-2021	Continued Improvements in Motor Milestones in Infants with Type 1 Spinal Muscular Atrophy After Two Years of Treatment with Evrysdi™	PTC Therapeutics, Inc.